Clinical efficacy evaluation of crisaborole ointment in the treatment of vulvar leukoplakia.

IF 1.2 4区医学 Q2 MEDICINE, GENERAL & INTERNAL Revista da Associacao Medica Brasileira Pub Date : 2023-02-17 eCollection Date: 2023-01-01 DOI:10.1590/1806-9282.20220801

Lijun Li

{"title":"Clinical efficacy evaluation of crisaborole ointment in the treatment of vulvar leukoplakia.","authors":"Lijun Li","doi":"10.1590/1806-9282.20220801","DOIUrl":null,"url":null,"abstract":"Objective: The aim of this study was to evaluate the clinical efficacy of crisaborole ointment in the treatment of vulvar leukoplakia.Methods: A prospective, randomized controlled clinical trial was conducted, and a total of 100 patients with vulvar leukoplakia were divided into the observation group (n=50) treated with crisaborole ointment and the control group (n=50) treated with vitamin E. The symptom improvement and vulvar leukoplakia score after 2 weeks of treatment were analyzed, and the clinical efficacy of vulvar leukoplakia was evaluated by referring to the Guidelines for Clinical Research of New Drugs of Traditional Chinese Medicine (2018 Edition).Results: After 2 weeks of treatment, the overall score of lesions in the observation group decreased, and the total treatment efficiency of patients in the observation group was 92% (46/50), which was significantly higher than that of 52% (26/50) in the control group P<0.05).Conclusion: Crisaborole ointment can effectively treat vulvar leukoplakia, improving the symptoms and pathological changes of the vulvar skin.","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":"69 1","pages":"97-100"},"PeriodicalIF":1.2000,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/da/3c/1806-9282-ramb-69-01-0097.PMC9937623.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista da Associacao Medica Brasileira","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1806-9282.20220801","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The aim of this study was to evaluate the clinical efficacy of crisaborole ointment in the treatment of vulvar leukoplakia.

Methods: A prospective, randomized controlled clinical trial was conducted, and a total of 100 patients with vulvar leukoplakia were divided into the observation group (n=50) treated with crisaborole ointment and the control group (n=50) treated with vitamin E. The symptom improvement and vulvar leukoplakia score after 2 weeks of treatment were analyzed, and the clinical efficacy of vulvar leukoplakia was evaluated by referring to the Guidelines for Clinical Research of New Drugs of Traditional Chinese Medicine (2018 Edition).

Results: After 2 weeks of treatment, the overall score of lesions in the observation group decreased, and the total treatment efficiency of patients in the observation group was 92% (46/50), which was significantly higher than that of 52% (26/50) in the control group P<0.05).

Conclusion: Crisaborole ointment can effectively treat vulvar leukoplakia, improving the symptoms and pathological changes of the vulvar skin.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

脆柏醇软膏治疗外阴白斑的临床疗效评估。

研究目的本研究旨在评估香脆硼酸软膏治疗外阴白斑的临床疗效：进行前瞻性随机对照临床试验，将100例外阴白斑患者分为使用脆柏醇软膏治疗的观察组（n=50）和使用维生素E治疗的对照组（n=50），分析治疗2周后的症状改善情况和外阴白斑评分，参照《中药新药临床研究指导原则（2018年版）》评价外阴白斑的临床疗效，结果：治疗2周后，观察组患者病灶总评分下降，观察组患者治疗总有效率为92%（46/50），明显高于对照组的52%（26/50）PC结论：克利博罗软膏能有效治疗外阴白斑，改善外阴皮肤的症状和病理变化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Revista da Associacao Medica Brasileira 医学-医学：内科

CiteScore

2.20

自引率

0.00%

发文量

276

审稿时长

12 weeks

期刊介绍： A Revista da Associação Médica Brasileira (RAMB), editada pela Associação Médica Brasileira, desde 1954, tem por objetivo publicar artigos que contribuam para o conhecimento médico.